Reyvow 50 mg/1
lasmiditan · TABLET · Eli Lilly and Company
Reyvow (lasmiditan) is an oral tablet used to treat acute migraine headaches in adults. It works by narrowing blood vessels and reducing substances in the body that can cause headaches, pain, sensitivity to light, sensitivity to sound, and nausea.
Key Facts
- Brand Name
- Reyvow
- Generic Name
- lasmiditan
- NDC Code (Product)
0002-4312- Manufacturer
- Eli Lilly and Company
- Strength
- 50 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule V (Controlled)
- Application #
- NDA211280
- Marketing Start
- 10/11/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Reyvow used for?
Reyvow (lasmiditan) is an oral tablet used to treat acute migraine headaches in adults. It works by narrowing blood vessels and reducing substances in the body that can cause headaches, pain, sensitivity to light, sensitivity to sound, and nausea.
Is Reyvow a controlled substance?
Yes, Reyvow is classified as CV under the DEA Controlled Substances Act.
What is the generic name for Reyvow?
The generic name for Reyvow is lasmiditan. There are no other listed brand versions of lasmiditan.
What is the NDC code for Reyvow 50 mg/1?
The NDC (National Drug Code) for Reyvow 50 mg/1 is 0002-4312, listed by Eli Lilly and Company.
Other Reyvow Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)